PROMOTING ACCESS TO AFRICAN RESEARCH

Egyptian Journal of Biochemistry and Molecular Biology

Log in or Register to get access to full text downloads.

Remember me or Register



DOWNLOAD FULL TEXT Open Access  DOWNLOAD FULL TEXT Subscription or Fee Access

MIR 129 5-P as a noninvasive prognostic biomarker of liver fibrosis in HCV Egyptian population

Shymaa E. Ayoub, Olfat G. Shaker, Essam A. Hassan, Tarek I. Ahmed, Naglaa A. Ahmed, Mostafa Y. Abdelwahed

Abstract


Background: Hepatic fibrosis is the inevitable pathological process of chronic hepatitis C (CHC), Accurate assessment of liver fibrosis has an important role in determining prognosis and to follow-up disease progression. Current aim was to evaluate MiR 129 5-p as a noninvasive serum marker for assessment of liver fibrosis in chronic hepatitis C Egyptian populations.

Subject and Methods: Eighty HCV patients complicated by liver fibrosis and 80 subjects were enrolled as controls. MiRNA expression level was tested using miScript SYBR Green PCR Kit (Qiagen, USA).

Results: Results showed significant differences between the HCV patients and controls as regard the mean± SD of expression level of MiR-129-5p with down- regulation in HCV patients (0.10±0.02) (P<0.0001) . The results also showed that MiR 129-5p relative expression level was significantly down-regulated in sever fibrosis (F3-F4) compared with mild fibrosis (F1-F2). ROC curve analysis showed the prognostic value of MiR 129-5p to differentiate between severe fibrosis (F3 and F4) from mild (F1, F2) (sensitivity=70% and specificity =90%).

Conclusion: miR-129- 5p might be a potential prognostic biomarker for liver fibrosis.

Keywords: Liver fibrosis, CHC, MiR129-5p




AJOL African Journals Online